Published in Am J Transplant on February 01, 2010
Transplantation tolerance through mixed chimerism. Nat Rev Nephrol (2010) 1.17
Induction of tolerance through mixed chimerism. Cold Spring Harb Perspect Med (2014) 0.97
LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L. Blood (2011) 0.91
Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev (2014) 0.86
Hematopoietic stem cell infusion/transplantation for induction of allograft tolerance. Curr Opin Organ Transplant (2015) 0.80
Experimental models of B cell tolerance in transplantation. Semin Immunol (2011) 0.77
Layers of regulation in induction of mixed chimerism by anti-CD40L. Chimerism (2012) 0.75
Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy. EBioMedicine (2016) 0.75
The B7 family revisited. Annu Rev Immunol (2005) 13.51
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol (2004) 10.08
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 8.94
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
B cells regulate autoimmunity by provision of IL-10. Nat Immunol (2002) 7.30
CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol (2002) 6.94
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12
Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med (2008) 4.04
Induction of self-tolerance in mature peripheral B lymphocytes. Nature (1989) 4.02
Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma (1984) 3.68
B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 3.37
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol (2007) 3.02
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol (2004) 2.77
Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med (2000) 2.61
Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol (2006) 2.38
Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity (1996) 2.28
Self-tolerance checkpoints in B lymphocyte development. Adv Immunol (1995) 1.97
Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J Immunol (1998) 1.81
Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells. Proc Natl Acad Sci U S A (1998) 1.80
Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A (1989) 1.75
Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med (1998) 1.65
CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev (1996) 1.60
B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol (2003) 1.56
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood (2008) 1.19
Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L. Am J Transplant (2004) 1.14
Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions. Blood (2001) 1.04
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance. Blood (2009) 1.04
Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. J Immunol (2008) 1.01
Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science (2000) 10.81
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
Contribution of increasing CO2 and climate to carbon storage by ecosystems in the United States. Science (2000) 2.51
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation (1999) 2.16
Pig hematopoietic cell chimerism in baboons conditioned with a nonmyeloablative regimen and CD154 blockade. Transplantation (2002) 2.15
Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest (1998) 1.99
Skin graft tolerance across a discordant xenogeneic barrier. Nat Med (1996) 1.86
Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest (2000) 1.86
Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol (1994) 1.77
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med (1998) 1.65
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant (2014) 1.49
Myelosuppressive conditioning is required to achieve engraftment of pluripotent stem cells contained in moderate doses of syngeneic bone marrow. Blood (1994) 1.44
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
Mixed chimerism and transplantation tolerance. Annu Rev Med (2001) 1.36
Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today (1988) 1.33
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant (2000) 1.33
Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant (1999) 1.28
B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans. Am J Transplant (2009) 1.27
A provisional database for the silicon content of foods in the United Kingdom. Br J Nutr (2005) 1.26
Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation (1998) 1.25
Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation (1999) 1.20
Results of gal-knockout porcine thymokidney xenografts. Am J Transplant (2009) 1.19
Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation (1996) 1.18
Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice. Blood (1997) 1.18
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant (2011) 1.17
Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med (1998) 1.17
Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation (1999) 1.16
Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol (2001) 1.16
Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med (1990) 1.15
A calcium requirement for the phosphatidylinositol response following activation of presynaptic muscarinic receptors. Biochem Pharmacol (1979) 1.13
Specific tolerance across a discordant xenogeneic transplantation barrier. Proc Natl Acad Sci U S A (1994) 1.13
Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J Immunol (2000) 1.12
Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Transplantation (1996) 1.12
High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation (2000) 1.10
Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Biol Blood Marrow Transplant (2001) 1.08
Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection. J Clin Invest (1999) 1.05
Xenotransplantation. Adv Immunol (2001) 1.05
Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J Immunol (2001) 1.04
Effects of neomycin on calcium and polyphosphoinositide metabolism of guinea pig synaptosomes. J Neurochem (1980) 1.03
The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation (1999) 1.03
Interleukin-12 inhibits graft-versus-host disease through an Fas-mediated mechanism associated with alterations in donor T-cell activation and expansion. Blood (1998) 1.03
Normal development in porcine thymus grafts and specific tolerance of human T cells to porcine donor MHC. J Immunol (1999) 1.00
IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Transplantation (1994) 0.99
Childhood bacterial meningitis beyond the neonatal period in southern Nigeria: changes in organisms/antibiotic susceptibility. East Afr Med J (1994) 0.98
Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras. Int Immunol (1998) 0.96
Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation. Biol Blood Marrow Transplant (2001) 0.96
Outcomes of recipients of both bone marrow and solid organ transplants. A review. Medicine (Baltimore) (1998) 0.96
Calcium ions and inositol phospholipid metabolism in nervous tissue. Biochem Soc Trans (1979) 0.95
Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2----P1) irradiation chimeras. Cell Immunol (1989) 0.95
Natural antibodies can inhibit bone marrow engraftment in the rat----mouse species combination. J Immunol (1991) 0.93
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen. Bone Marrow Transplant (2007) 0.92
Natural antibodies against bone marrow cells of a concordant xenogeneic species. J Immunol (1991) 0.91
Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells. Am J Transplant (2001) 0.90
Natural killer cells and their role in graft rejection. Curr Opin Immunol (1998) 0.90
Thymic transplantation across an MHC class I barrier in swine. J Immunol (1999) 0.89
Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation (1996) 0.89
Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant (1992) 0.89
Induction of human T-cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system. Am J Transplant (2009) 0.89
Positive and negative selection of functional mouse CD4 cells by porcine MHC in pig thymus grafts. J Immunol (1997) 0.89
Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance. Biol Blood Marrow Transplant (2001) 0.88
The importance of nonimmune factors in reconstitution by discordant xenogeneic hematopoietic cells. Transplantation (1994) 0.87
American society of transplantation symposium on B cells in transplantation: harnessing humoral immunity from rodent models to clinical practice. Am J Transplant (2007) 0.87
Immune restoration by fetal pig thymus grafts in T cell-depleted, thymectomized mice. J Immunol (1997) 0.87
Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells. Transplantation (1995) 0.87
Long-term islet allograft function in the absence of chronic immunosuppression: a case report of a nonhuman primate previously made tolerant to a renal allograft from the same donor. Transplantation (2001) 0.87
In vivo T-cell depletion enhances production of anti-GALalpha1,3GAL natural antibodies in alpha1,3-galactosyltransferase-deficient mice. Transplantation (2000) 0.86
The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD. Leuk Lymphoma (1999) 0.85
The induction of specific pig skin graft tolerance by grafting with neonatal pig thymus in thymectomized mice. Transplantation (2000) 0.84
Interleukin-12 prevents severe acute graft-versus-host disease (GVHD) and GVHD-associated immune dysfunction in a fully major histocompatibility complex haplotype-mismatched murine bone marrow transplantation model. Transplantation (1997) 0.84
Efficacy of adhesive interactions in pig-to-human xenotransplantation. Immunol Today (1999) 0.84
Pig MHC mediates positive selection of mouse CD4+ T cells with a mouse MHC-restricted TCR in pig thymus grafts. J Immunol (1998) 0.84
Effects of streptozocin-induced diabetes on glucose metabolism and lactate release by isolated fat cells from young lean and older, moderately obese rats. Diabetes (1989) 0.84
Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation (2001) 0.84
Assessment of potential (inhalation and dermal) and actual exposure to acetamiprid by greenhouse applicators using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.83
Mixed hematopoietic chimerism and transplantation tolerance. Immunol Res (1997) 0.83
A novel application of cyclosporine A in nonmyeloablative pretransplant host conditioning for allogeneic BMT. Blood (2000) 0.83
Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade. Transplant Proc (1999) 0.83
Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism. Am J Transplant (2005) 0.82
B-cell reconstitution and xenoreactive anti-pig natural antibody production in severe combined immunodeficient mice reconstituted with immunocompetent B cells from varying sources. Transplantation (1998) 0.82
Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen. Transplantation (1992) 0.82
Porcine stem cell engraftment and seeding of murine thymus with class II+ cells in mice expressing porcine cytokines: toward tolerance induction across discordant xenogeneic barriers. Transplantation (2000) 0.82
Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC. Cell Mol Biol (Noisy-le-grand) (2001) 0.81
Highly disparate xenogeneic skin graft tolerance induction by fetal pig thymus in thymectomized mice: Conditioning requirements and the role of coimplantation of fetal pig liver. Transplantation (2001) 0.81
T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation (2001) 0.81
Effect of natural killer cell depletion on long-term multilineage allogeneic bone marrow engraftment. Transplant Proc (1993) 0.81
Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population. J Immunol (1992) 0.81
Cross-species interaction of porcine and human integrins with their respective ligands: implications for xenogeneic tolerance induction. Transplantation (1998) 0.81
Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level. J Immunol (1999) 0.80
Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J Immunol (1995) 0.80
Xenogeneic thymic transplantation in a pig-to-nonhuman primate model. Transplant Proc (1999) 0.80
Humoral tolerance in mixed xenogeneic chimeras prepared by a nonmyeloablative conditioning regimen. Transplant Proc (1991) 0.80
Global unresponsiveness as a mechanism of natural killer cell tolerance in mixed xenogeneic chimeras. Am J Transplant (2007) 0.80
Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells. Bone Marrow Transplant (1996) 0.80